Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ampio Pharmaceuticals AMPED

Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and advancement of immunomodulatory therapies for the treatment of pain from osteoarthritis. Its lead product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19 induced respiratory distress.


Recent & Breaking News (OTCPK:AMPED)

AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS

PR Newswire January 17, 2023

Ampio Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards

PR Newswire December 27, 2022

Ampio Pharmaceuticals Announces NYSE American Removal of Trading Suspension

PR Newswire November 17, 2022

Ampio Pharmaceuticals Announces Fifteen-to-One Reverse Stock Split

PR Newswire November 8, 2022

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Ampio Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 17, 2022 - (NYSE: AMPE)

PR Newswire October 19, 2022

DEADLINE TODAY: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

Newsfile October 17, 2022

AMPE DEADLINE TODAY: ROSEN, A TOP RANKED FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action - AMPE

Newsfile October 17, 2022

FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

Accesswire October 17, 2022

Ampio Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 17, 2022 to Discuss Your Rights - AMPE

Newsfile October 16, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ampio Pharmaceuticals, Inc. - AMPE

Newsfile October 16, 2022

Ampio Deadline Alert

Newsfile October 16, 2022

AMPE DEADLINE TOMORROW: ROSEN, skilled investor counsel, Encourages Ampio Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important October 17 Deadline in Securities Class Action - AMPE

PR Newswire October 16, 2022

AMPIO DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Ampio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

Business Wire October 14, 2022

AMPE DEADLINE ALERT: ROSEN, A TOP RANKED FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action - AMPE

Newsfile October 14, 2022

Ampio Pharmaceuticals Issues Letter to Stockholders

PR Newswire October 14, 2022

Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ampio Pharmaceuticals, Inc. (AMPE) Investors of Class Action and to Actively Participate

Business Wire October 14, 2022

MONDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

Newsfile October 14, 2022

AMPE SHAREHOLDER ALERT: Jakubowitz Law Reminds Ampio Shareholders of a Lead Plaintiff Deadline of October 17, 2022

PR Newswire October 14, 2022

Ampio Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 17, 2022 to Discuss Your Rights - AMPE

Newsfile October 13, 2022

Ampio Deadline Alert

Newsfile October 13, 2022